235 related articles for article (PubMed ID: 15608506)
21. Questionability of the benefits of routine laparotomy as the surgical approach for pheochromocytomas and abdominal paragangliomas.
Pattou FN; Combemale FP; Poirette JF; Carnaille B; Wemeau JL; Huglo D; Ernst O; Proye CA
Surgery; 1996 Dec; 120(6):1006-11; discussion 1012. PubMed ID: 8957487
[TBL] [Abstract][Full Text] [Related]
22. [Malignant pheochromocytoma].
Tanabe A; Tsuiki M; Takano K; Naruse M
Nihon Rinsho; 2006 May; Suppl 1():739-43. PubMed ID: 16776263
[No Abstract] [Full Text] [Related]
23. Adrenal and extra-adrenal nonfunctioning composite pheochromocytoma/paraganglioma with immunohistochemical ectopic hormone expression: comparison of two cases.
Gong J; Wang X; Chen X; Chen N; Huang R; Lu C; Chen D; Zeng H; Zhou Q
Urol Int; 2010; 85(3):368-72. PubMed ID: 20829582
[TBL] [Abstract][Full Text] [Related]
24. [Rational diagnosis in primary and recurrent pheochromocytoma].
Hiller WF; Schuppert F; Mössinger E; Pichlmayr R
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():422-4. PubMed ID: 9574170
[TBL] [Abstract][Full Text] [Related]
25. Cardiac complications as initial manifestation of pheochromocytoma: frequency, outcome, and predictors.
Yu R; Nissen NN; Bannykh SI
Endocr Pract; 2012; 18(4):483-92. PubMed ID: 22297057
[TBL] [Abstract][Full Text] [Related]
26. Pheochromocytomas and Hypertension.
Pappachan JM; Tun NN; Arunagirinathan G; Sodi R; Hanna FWF
Curr Hypertens Rep; 2018 Jan; 20(1):3. PubMed ID: 29356966
[TBL] [Abstract][Full Text] [Related]
27. Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry.
Yoshinaga K; Oriuchi N; Wakabayashi H; Tomiyama Y; Jinguji M; Higuchi T; Kayano D; Fukuoka M; Inaki A; Toratani A; Okamoto S; Shiga T; Ito YM; Nakajo M; Nakajo M; Kinuya S; ; ;
Endocr J; 2014; 61(12):1171-80. PubMed ID: 25214026
[TBL] [Abstract][Full Text] [Related]
28. [An incidental finding of retrocaval extraadrenal pheochromocytoma].
Bretterbauer KM; Colleselli D; Magdy A; Janetschek G; Mitterberger M
Wien Med Wochenschr; 2015 Oct; 165(19-20):406-9. PubMed ID: 26169994
[TBL] [Abstract][Full Text] [Related]
29. [CME: Pheochromocytoma in the General Practice].
Erlic Z; Fischli S
Praxis (Bern 1994); 2018 Aug; 107(17-18):977-984. PubMed ID: 30131024
[TBL] [Abstract][Full Text] [Related]
30. Localization of mediastinal paragangliomas (pheochromocytoma).
Sheps SG; Brown ML
Chest; 1985 Jun; 87(6):807-9. PubMed ID: 3996072
[No Abstract] [Full Text] [Related]
31. Successful removal of large adrenal pheochromocytoma on the right side with liver mobilization.
Aoyama N; Sasagawa I; Iijima Y; Suzuki H; Kubota Y; Nakada T
Int Urol Nephrol; 1998; 30(4):377-84. PubMed ID: 9821037
[TBL] [Abstract][Full Text] [Related]
32. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
[TBL] [Abstract][Full Text] [Related]
33. Posterior mediastinal paraganglioma with bilateral adrenal pheochromocytoma.
Kwon HJ; Park JH; Jin GY; Chung MJ; Lim ST; Kim MH; Kim HJ; Lee YC
Respir Med; 2004 Jun; 98(6):574-6. PubMed ID: 15191044
[TBL] [Abstract][Full Text] [Related]
34. Pheochromocytoma: presentation, diagnosis and treatment.
Reisch N; Peczkowska M; Januszewicz A; Neumann HP
J Hypertens; 2006 Dec; 24(12):2331-9. PubMed ID: 17082709
[TBL] [Abstract][Full Text] [Related]
35. Adrenal gland scintigraphy.
Avram AM; Fig LM; Gross MD
Semin Nucl Med; 2006 Jul; 36(3):212-27. PubMed ID: 16762612
[TBL] [Abstract][Full Text] [Related]
36. [Recent advances in adrenal diseases].
Gruber M; Eisenhofer G; Fassnacht M; Bornstein SR
Dtsch Med Wochenschr; 2011 Oct; 136(40):1998-2001. PubMed ID: 21960326
[No Abstract] [Full Text] [Related]
37. Phaeochromocytomas and functional paragangliomas: clinical management.
Plouin PF; Amar L; Lepoutre C
Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):933-41. PubMed ID: 21115162
[TBL] [Abstract][Full Text] [Related]
38. Recent developments in the therapy of phaeochromocytoma.
Chew SL
Expert Opin Investig Drugs; 2004 Dec; 13(12):1579-83. PubMed ID: 15566315
[TBL] [Abstract][Full Text] [Related]
39. [Pheochromocytoma and paraganglioma in childhood: a report of 2 cases report].
Mosquera Gorostidi A; Justo Ranera A; Zakirian Denis SE; González Temprano N; Sagaseta de Ilúrdoz Uranga M; Molina Garicano J
An Pediatr (Barc); 2015 Jan; 82(1):e175-80. PubMed ID: 25082130
[TBL] [Abstract][Full Text] [Related]
40. Use of fusion images of I-131 metaiodobenzylguanidine, SPECT, and magnetic resonance studies to identify a malignant pheochromocytoma.
Fujita A; Hyodoh H; Kawamura Y; Kanegae K; Furuse M; Kanazawa K
Clin Nucl Med; 2000 Jun; 25(6):440-2. PubMed ID: 10836692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
